A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8233 in healthy male subjects with increased elevated LDL-C levels.

Trial Identifier: D7990C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03593785
Start Date: August 2018
Primary Completion Date: December 2020
Study Completion Date: December 2020
Condition: Hypercholesterolemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation
Simplified Chinese Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206